Skip to main navigation Skip to search Skip to main content

Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment

Project: Research

Project Details

StatusFinished
Effective start/end date06/1/2405/31/26

Funding

  • National Institute of Allergy & Infectious Disease: $342,151.00